Search Editorial Photos
"Phase 3 Study"
63 professional editorial images found
#10050036
16 May 2023
A single oral dose of azithromycin was found to significantly lower the risk of maternal sepsis or death among women planning a vaginal delivery, according to new data published in The New England Journal of Medicine. The National Institutes of Health (NIH)-led phase 3 study included 29,278 women who were in labor at 28 weeks' gestation or more and who were planning a vaginal delivery. This photo was taken at a pharmacy in Tehatta, West Bengal; India on 16/05/2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10050042
16 May 2023
A single oral dose of azithromycin was found to significantly lower the risk of maternal sepsis or death among women planning a vaginal delivery, according to new data published in The New England Journal of Medicine. The National Institutes of Health (NIH)-led phase 3 study included 29,278 women who were in labor at 28 weeks' gestation or more and who were planning a vaginal delivery. This photo was taken at a pharmacy in Tehatta, West Bengal; India on 16/05/2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198050
19 Nov 2020
Vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198052
19 Nov 2020
A medical syringe in front of the AstraZeneca British biopharmaceutical company logo is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198054
19 Nov 2020
A medical syringe and vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198056
19 Nov 2020
A medical syringe and vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198058
19 Nov 2020
A medical syringe and a vial in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198090
19 Nov 2020
A medical syringe and vials in front of the World Health Organization (WHO) logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198092
19 Nov 2020
A medical syringe and a vial in front of the World Health Organization (WHO) logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198094
19 Nov 2020
A medical syringe and vials in front of the World Health Organization (WHO) logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198096
19 Nov 2020
Vials in front of the World Health Organization (WHO) logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198098
19 Nov 2020
A medical syringe and vials in front of the World Health Organization (WHO) world map of the COVID-19 coronavirus cases are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198100
19 Nov 2020
A medical syringe and a vial in front of the World Health Organization (WHO) world map of the COVID-19 coronavirus cases are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198102
19 Nov 2020
A medical syringe and a vial in front of the World Health Organization (WHO) world map of the COVID-19 coronavirus cases are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198104
19 Nov 2020
A medical syringe and vials in front of the flag of Germany are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198106
19 Nov 2020
A medical syringe and a vial in front of the EU flag are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 coronavirus vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.